These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29059479)

  • 1. Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study.
    Ward ST; Mytton J; Henderson L; Amin V; Tanner JR; Evison F; Radley S
    Colorectal Dis; 2018 May; 20(5):416-423. PubMed ID: 29059479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.
    Kulaylat AS; Kulaylat AN; Schaefer EW; Tinsley A; Williams E; Koltun W; Hollenbeak CS; Messaris E
    JAMA Surg; 2017 Aug; 152(8):e171538. PubMed ID: 28614561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
    Zittan E; Milgrom R; Ma GW; Wong-Chong N; OʼConnor B; McLeod RS; MacRae HM; Greenberg GR; Nguyen GC; Croitoru K; Steinhart AH; Cohen Z; Silverberg MS
    Inflamm Bowel Dis; 2016 Oct; 22(10):2442-7. PubMed ID: 27607335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.
    Kim JY; Zaghiyan K; Lightner A; Fleshner P
    BMC Surg; 2020 Mar; 20(1):46. PubMed ID: 32138717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab and complications after colectomy in patients with ulcerative colitis.
    Bregnbak D; Mortensen C; Bendtsen F
    J Crohns Colitis; 2012 Apr; 6(3):281-6. PubMed ID: 22405163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative complications and mortality following colectomy for ulcerative colitis.
    de Silva S; Ma C; Proulx MC; Crespin M; Kaplan BS; Hubbard J; Prusinkiewicz M; Fong A; Panaccione R; Ghosh S; Beck PL; Maclean A; Buie D; Kaplan GG
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):972-80. PubMed ID: 21806954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease.
    Monsinjon M; Mege D; Maggiori L; Treton X; Bouhnik Y; Panis Y
    Int J Colorectal Dis; 2017 Oct; 32(10):1499-1502. PubMed ID: 28681072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy.
    Gu J; Remzi FH; Shen B; Vogel JD; Kiran RP
    Dis Colon Rectum; 2013 Nov; 56(11):1243-52. PubMed ID: 24104999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.
    Ma C; Beilman CL; Huang VW; Fedorak DK; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    Can J Gastroenterol Hepatol; 2016; 2016():2079582. PubMed ID: 27478817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
    Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
    J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of disease may predict response to infliximab in pediatric ulcerative colitis.
    Mir SA; Nagy-Szakal D; Smith EO; Gilger MA; Kellermayer R
    J Clin Gastroenterol; 2014 Mar; 48(3):248-52. PubMed ID: 24129407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Surgical Morbidity for Ulcerative Colitis Patients in the Era of Biologics.
    Abelson JS; Michelassi F; Mao J; Sedrakyan A; Yeo H
    Ann Surg; 2018 Aug; 268(2):311-317. PubMed ID: 28448381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Huguet M; Pereira B; Goutte M; Goutorbe F; Dubois A; Bommelaer G; Buisson A
    Inflamm Bowel Dis; 2018 Jan; 24(2):261-268. PubMed ID: 29361101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients: comparison of retrospective cohorts.
    Sajjadi S; Svensson Neufert R; Ruhr E; Tryggmo S; Marsal J; Buchwald P
    Scand J Gastroenterol; 2023 Jan; 58(1):15-19. PubMed ID: 35917586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
    Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy.
    Ferrante M; de Buck van Overstraeten A; Schils N; Moens A; Van Assche G; Wolthuis A; Vermeire S; D'Hoore A
    J Crohns Colitis; 2017 Oct; 11(11):1353-1361. PubMed ID: 28981886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.